Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 2/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.32 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.32 |
| ▸ | AGPAT2 | O15120 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
| ▸ | JUN | P05412 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1026330 | 0.78 | AGPAT2 (0.49) | S1PR1AGPAT2 | |
| SCHEMBL14840893 | 0.74 | PIM1 (0.42) | PIM1PIM2FFAR1MAOAMAOB | |
| SCHEMBL11895536 | 0.68 | ILK (0.50) | AGPAT2 | |
| SCHEMBL1025362 | 0.68 | S1PR1 (0.35) | S1PR1AGPAT2 | |
| Iodide SCHEMBL10902927 | 0.67 | FFAR1 (0.46) | PIM1PIM2FFAR1MAOAMAOB | |
| SCHEMBL1023504 | 0.67 | AGPAT2 (0.43) | S1PR1AGPAT2 | |
| SCHEMBL1025013 | 0.66 | AGPAT2 (0.44) | S1PR1AGPAT2NFKB1NFKB2RELA | |
| SCHEMBL1024762 | 0.66 | AGPAT2 (0.44) | AGPAT2 | |
| SCHEMBL14840456 | 0.65 | PIM1 (0.43) | PIM1PIM2FFAR1MAOAMAOB | |
| SCHEMBL10901776 | 0.64 | FFAR1 (0.52) | PIM1PIM2FFAR1MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8796306-B2 | Noxious arthropod controlling composition and heterocyclic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-05 | — | — | US | disclosed |
| US-20130090353-A1 | NOXIOUS ARTHROPOD CONTROL COMPOSITION AND HETEROCYCLIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130090353-A1 | NOXIOUS ARTHROPOD CONTROL COMPOSITION AND HETEROCYCLIC COMPOUND | C5, C3AR1, TRPA1 | PIM1 4830/4885PIM2 4859/4885FFAR1 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.